The JAK inhibitor ruxolitinib impairs dendritic cell migration via off-target inhibition of ROCK.

Leukemia

Medical Clinic 3, Oncology, Hematology, Immunoncology and Rheumatology, University Clinic Bonn (UKB), Bonn, Germany.

Published: October 2016

Download full-text PDF

Source
http://dx.doi.org/10.1038/leu.2016.155DOI Listing

Publication Analysis

Top Keywords

jak inhibitor
4
inhibitor ruxolitinib
4
ruxolitinib impairs
4
impairs dendritic
4
dendritic cell
4
cell migration
4
migration off-target
4
off-target inhibition
4
inhibition rock
4
jak
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!